Click here for more information about saquinavir [clinicaltrials_resource:37f2e420e1ebd4e8f4cba6bdc4933345]
Immunologic and Virologic Consequences of Long-Term Highly Active Antiretroviral Therapy (HAART) in Subjects With Moderately Advanced HIV-1 Disease: A Follow-Up Study to ACTG 315 [clinicaltrials:NCT00000891]A Study of Several Anti-HIV Drug Combinations in HIV-Infected Patients Who Have Used Indinavir [clinicaltrials:NCT00000892]Interactions of HIV Protease Inhibitors and Methadone in HIV-Infected Patients [clinicaltrials:NCT00000906]A Study on Amprenavir in Combination With Other Anti-HIV Drugs in HIV-Positive Patients [clinicaltrials:NCT00000912]A Study to Compare Two Anti-HIV Combination Therapies Each Containing Saquinavir in HIV-Positive Children [clinicaltrials:NCT00000913]A Study to Compare The Ability of Different Anti-HIV Drugs to Decrease Viral Load After Nelfinavir (an Anti-HIV Drug)Treatment Failure [clinicaltrials:NCT00000918]Fortovase (Saquinavir) Given With Low-Dose Ritonavir, Zidovudine, and Lamivudine to HIV-Positive Pregnant Women During and After Pregnancy and to Their Newborns [clinicaltrials:NCT00000920]Comparison of Ro 31-8959 Plus Zidovudine (AZT) Versus AZT Plus Zalcitabine (ddC) Versus Ro 31-8959 Plus AZT Plus ddC [clinicaltrials:NCT00001040]The Effectiveness of Nelfinavir and Efavirenz, Used Alone or Together, Combined With Other Anti-HIV Drugs in Patients Who Have Taken Anti-HIV Drugs [clinicaltrials:NCT00001087]Drug Interactions of Amprenavir and Efavirenz, in Combination With a Second Protease Inhibitor, in HIV-Negative Volunteers [clinicaltrials:NCT00005762]clinicaltrials:NCT00051831Safety of Saquinavir and High Doses of Lopinavir/Ritonavir in Children With HIV [clinicaltrials:NCT00084058]
link [clinicaltrials_vocabulary:link]
Click here for more information about saquinavir [clinicaltrials_resource:37f2e420e1ebd4e8f4cba6bdc4933345]
Bio2RDF identifier
37f2e420e1ebd4e8f4cba6bdc4933345
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:37f2e420e1ebd4e8f4cba6bdc4933345
url [clinicaltrials_vocabulary:url]
identifier
clinicaltrials_resource:37f2e420e1ebd4e8f4cba6bdc4933345
title
Click here for more information about saquinavir
@en
type
label
Click here for more informatio ...... 2e420e1ebd4e8f4cba6bdc4933345]
@en